Skip to search formSkip to main contentSkip to account menu

Champix

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
Objectives: The aim of this thesis is to explore how anti-tobacco messages can be made more salient for Indigenous smokers… 
2013
2013
There are an estimated 1.3 billion smokers worldwide, and nearly six million people die from tobacco-related diseases each year… 
2013
2013
BackgroundVarenicline (Champix®), launched in the UK in December 2006, is indicated for the treatment of smoking cessation in… 
2011
2011
Cost-effectiveness analysis, even with its inherent methodological problems, consistently shows that when smoking cessation… 
2010
2010
different cancers, lung diseases and cardiovascular diseases. About 21% of the Norwegian population are daily smokers. In Norway… 
2008
2008
Objective: To analyse the efficiency of varenicline compared with bupropion, NRT (nicotine replacement therapy) and no… 
2008
2008
OBJECTIVE To analyse the efficiency of varenicline compared with bupropion, NRT (nicotine replacement therapy) and no… 
Review
2007
Review
2007
Varenicline is a well‐tolerated novel treatment to aid smoking cessation in adults that is generally more effective than existing… 
2007
2007
Smoking is responsible for 20,000 premature deaths per year in Belgium. Paradoxically, few drugs are efficient to induce tobacco…